Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeEAM Conditioning for Multiple Myeloma ASCT
NCT02416206Phase 2Completed
- Sponsor
- Northside Hospital
- Start
- Apr 2015
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in multiple myeloma (MM), sponsored by Northside Hospital. Started Apr 2015; status: completed.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02416206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02416206.